サマリー

世界の抗CD20モノクローナル抗体（mABs）市場 2022-2026
Technavioは、抗CD20モノクローナル抗体（mABs）市場を監視しており、それは2022-2026年の間に90億5000万ドルで、予測期間中にCAGR9.81％で進行することが予測されています。当レポートでは、抗cd20モノクローナル抗体（mABs）市場の全体分析、市場規模・予測、動向、成長ドライバー、課題、さらに約25社のベンダーを網羅したベンダー分析などを提供しています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、併用療法の増加、抗CD20 mABsの高い標的親和性と特異性、強力なパイプラインと最近の承認によって牽引されています。
抗CD20モノクローナル抗体（mABs）市場の分析には、製品セグメントと地理的展望が含まれます。
Technavioの抗CD20モノクローナル抗体（mABs）市場は、以下のように区分されています。
製品別
- オンコロジー
- 神経学
- 免疫学
地域別
- 北アメリカ
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、今後数年間における抗CD20モノクローナル抗体（mABs）市場の成長を促進する主要な理由の一つとして、治療領域に関する認知度の向上を挙げています。また、償還制度や患者支援プログラムの存在、CD20二重特異性抗体の開発は、市場の大きな需要につながるでしょう。
Technavio社は、複数のソースからのデータの調査、合成、主要パラメータの分析による総括の方法により、市場の詳細なイメージを提示します。抗CD20モノクローナル抗体（mAB）市場に関する当レポートは、以下の分野を対象としています。
- 抗CD20モノクローナル抗体（mABs）市場のサイジング
- 抗CD20モノクローナル抗体（mABs）市場予測
- 抗CD20モノクローナル抗体（mABs）市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されています。これに沿って、本レポートでは、Acrotech Biopharma、Amgen Inc、AstraZeneca Plc、Celltrion Healthcare Co.Ltd.、F. Hoffmann La Roche Ltd.、Fosun International Ltd.、Genmab AS、IGM Biosciences Inc.、JSC BIOCAD、LFB SA、Novartis AG、Pfizer Inc、Regeneron Pharmaceuticals Inc、Spectrum Pharmaceuticals Inc、TG Therapeutics Inc、United BioPharma IncおよびZheJiang HISUN PHARMACEUTICAL Co.Ltd.が開発しました。また、抗CD20モノクローナル抗体（mABs）市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略的に活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、以下をご覧ください - [https://www.technavio.com/report/anti-cd20-monoclonal-antibodies-mABs-market-size-industry-analysis](https://www.technavio.com/report/anti-cd20-monoclonal-antibodies-mabs-market-size-industry-analysis)
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法によって、市場の詳細なイメージを提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Product
o 5.1 Market segments
o Exhibit 24: Chart on Product - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
o 5.2 Comparison by Product
o Exhibit 26: Chart on Comparison by Product
o Exhibit 27: Data Table on Comparison by Product
o 5.3 Oncology - Market size and forecast 2021-2026
o Exhibit 28: Chart on Oncology - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Oncology - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Oncology - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Oncology - Year-over-year growth 2021-2026 (%)
o 5.4 Neurology - Market size and forecast 2021-2026
o Exhibit 32: Chart on Neurology - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Neurology - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Neurology - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Neurology - Year-over-year growth 2021-2026 (%)
o 5.5 Immunology - Market size and forecast 2021-2026
o Exhibit 36: Chart on Immunology - Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Immunology - Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Immunology - Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Immunology - Year-over-year growth 2021-2026 (%)
o 5.6 Market opportunity by Product
o Exhibit 40: Market opportunity by Product ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 44: Chart on Geographic comparison
o Exhibit 45: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Canada - Market size and forecast 2021-2026
o Exhibit 66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.9 Mexico - Market size and forecast 2021-2026
o Exhibit 70: Chart on Mexico - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on Mexico - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on Mexico - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on Mexico - Year-over-year growth 2021-2026 (%)
o 7.10 Germany - Market size and forecast 2021-2026
o Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.11 UK - Market size and forecast 2021-2026
o Exhibit 78: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 82: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 83: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 85: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 86: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 87: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 88: Matrix on vendor position and classification
o 10.3 Acrotech Biopharma
o Exhibit 89: Acrotech Biopharma - Overview
o Exhibit 90: Acrotech Biopharma - Product / Service
o Exhibit 91: Acrotech Biopharma - Key offerings
o 10.4 Amgen Inc.
o Exhibit 92: Amgen Inc. - Overview
o Exhibit 93: Amgen Inc. - Product / Service
o Exhibit 94: Amgen Inc. - Key offerings
o 10.5 Celltrion Healthcare Co. Ltd.
o Exhibit 95: Celltrion Healthcare Co. Ltd. - Overview
o Exhibit 96: Celltrion Healthcare Co. Ltd. - Product / Service
o Exhibit 97: Celltrion Healthcare Co. Ltd. - Key offerings
o 10.6 F. Hoffmann La Roche Ltd.
o Exhibit 98: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 99: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 100: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 101: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 102: F. Hoffmann La Roche Ltd. - Segment focus
o 10.7 IGM Biosciences Inc.
o Exhibit 103: IGM Biosciences Inc. - Overview
o Exhibit 104: IGM Biosciences Inc. - Product / Service
o Exhibit 105: IGM Biosciences Inc. - Key offerings
o 10.8 LFB SA
o Exhibit 106: LFB SA - Overview
o Exhibit 107: LFB SA - Product / Service
o Exhibit 108: LFB SA - Key offerings
o 10.9 Novartis AG
o Exhibit 109: Novartis AG - Overview
o Exhibit 110: Novartis AG - Business segments
o Exhibit 111: Novartis AG - Key offerings
o Exhibit 112: Novartis AG - Segment focus
o 10.10 Pfizer Inc.
o Exhibit 113: Pfizer Inc. - Overview
o Exhibit 114: Pfizer Inc. - Product / Service
o Exhibit 115: Pfizer Inc. - Key news
o Exhibit 116: Pfizer Inc. - Key offerings
o 10.11 Regeneron Pharmaceuticals Inc.
o Exhibit 117: Regeneron Pharmaceuticals Inc. - Overview
o Exhibit 118: Regeneron Pharmaceuticals Inc. - Product / Service
o Exhibit 119: Regeneron Pharmaceuticals Inc. - Key offerings
o 10.12 TG Therapeutics Inc.
o Exhibit 120: TG Therapeutics Inc. - Overview
o Exhibit 121: TG Therapeutics Inc. - Product / Service
o Exhibit 122: TG Therapeutics Inc. - Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 123: Inclusions checklist
o Exhibit 124: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 125: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 126: Research methodology
o Exhibit 127: Validation techniques employed for market sizing
o Exhibit 128: Information sources
o 11.5 List of abbreviations
o Exhibit 129: List of abbreviations

Exhibits
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Product - Market share 2021-2026 (%)
Exhibits25: Data Table on Product - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Product
Exhibits27: Data Table on Comparison by Product
Exhibits28: Chart on Oncology - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Oncology - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Oncology - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Oncology - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Neurology - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Neurology - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Neurology - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Neurology - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Immunology - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Immunology - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Immunology - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Immunology - Year-over-year growth 2021-2026 (%)
Exhibits40: Market opportunity by Product ($ million)
Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits44: Chart on Geographic comparison
Exhibits45: Data Table on Geographic comparison
Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Mexico - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Mexico - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Mexico - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Mexico - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits82: Market opportunity By Geographical Landscape ($ million)
Exhibits83: Impact of drivers and challenges in 2021 and 2026
Exhibits84: Overview on Criticality of inputs and Factors of differentiation
Exhibits85: Overview on factors of disruption
Exhibits86: Impact of key risks on business
Exhibits87: Vendors covered
Exhibits88: Matrix on vendor position and classification
Exhibits89: Acrotech Biopharma - Overview
Exhibits90: Acrotech Biopharma - Product / Service
Exhibits91: Acrotech Biopharma - Key offerings
Exhibits92: Amgen Inc. - Overview
Exhibits93: Amgen Inc. - Product / Service
Exhibits94: Amgen Inc. - Key offerings
Exhibits95: Celltrion Healthcare Co. Ltd. - Overview
Exhibits96: Celltrion Healthcare Co. Ltd. - Product / Service
Exhibits97: Celltrion Healthcare Co. Ltd. - Key offerings
Exhibits98: F. Hoffmann La Roche Ltd. - Overview
Exhibits99: F. Hoffmann La Roche Ltd. - Business segments
Exhibits100: F. Hoffmann La Roche Ltd. - Key news
Exhibits101: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits102: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits103: IGM Biosciences Inc. - Overview
Exhibits104: IGM Biosciences Inc. - Product / Service
Exhibits105: IGM Biosciences Inc. - Key offerings
Exhibits106: LFB SA - Overview
Exhibits107: LFB SA - Product / Service
Exhibits108: LFB SA - Key offerings
Exhibits109: Novartis AG - Overview
Exhibits110: Novartis AG - Business segments
Exhibits111: Novartis AG - Key offerings
Exhibits112: Novartis AG - Segment focus
Exhibits113: Pfizer Inc. - Overview
Exhibits114: Pfizer Inc. - Product / Service
Exhibits115: Pfizer Inc. - Key news
Exhibits116: Pfizer Inc. - Key offerings
Exhibits117: Regeneron Pharmaceuticals Inc. - Overview
Exhibits118: Regeneron Pharmaceuticals Inc. - Product / Service
Exhibits119: Regeneron Pharmaceuticals Inc. - Key offerings
Exhibits120: TG Therapeutics Inc. - Overview
Exhibits121: TG Therapeutics Inc. - Product / Service
Exhibits122: TG Therapeutics Inc. - Key offerings
Exhibits123: Inclusions checklist
Exhibits124: Exclusions checklist
Exhibits125: Currency conversion rates for US$
Exhibits126: Research methodology
Exhibits127: Validation techniques employed for market sizing
Exhibits128: Information sources
Exhibits129: List of abbreviations